FIVN Stock Analysis: Five9 | NASDAQ
Software - Infrastructure | NASDAQ, USA | Market Cap: 1.959m USD | 12M Return: -12.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 51.6M
EPS Trend: 83.8%
Qual. Beats: 1
Rev. Trend: 99.6%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Five9, Inc. (NASDAQ: FIVN) is a U.S.-based provider of intelligent cloud software for contact centers, operating in the international market as well. The company is classified within the Application Software sub-industry of the Information Technology sector, a segment that commonly relies on recurring subscription revenue rather than one-time license sales.
Its flagship CX platform combines a suite of applications-including AI agents, agent assist, workflow automation, AI insights, AI summaries, workforce engagement management, and revenue execution-to support customer service, sales, and marketing functions. The platform enables organizations to manage and optimize customer interactions across voice, chat, email, web, social media, and mobile channels, while integrating with adjacent enterprise applications such as CRM software to deliver real-time customer data to agents. This delivery model is consistent with the software-as-a-service (SaaS) approach used across most of the application software space, where customers access the product remotely rather than installing on-premise software.
Five9 serves clients across a diverse set of industries, including banking and financial services, business process outsourcers, retail, healthcare, technology, and education. The company was incorporated in 2001, is headquartered in San Ramon, California, and has been publicly traded since its April 2014 IPO.
- AI agents adoption accelerates enterprise contact center deals
- Subscription ARR growth drives recurring revenue expansion
- Competition from Genesys pressures pricing and operating margins
| Net Income: 57.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 5.91 > 1.0 |
| NWC/Revenue: 66.62% < 20% (prev 60.35%; Δ 6.27% < -1%) |
| CFO/TA 0.13 > 3% & CFO 241.7m > Net Income 57.3m |
| Net Debt (140.4m) to EBITDA (185.9m): 0.76 < 3 |
| Current Ratio: 4.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (86.3m) vs 12m ago -3.33% < -2% |
| Gross Margin: 55.10% > 18% (prev 54.50%; Δ 0.60% > 0.5%) |
| Asset Turnover: 59.40% > 50% (prev 51.42%; Δ 7.98% > 0%) |
| Interest Coverage Ratio: 5.94 > 6 (EBIT TTM 77.8m / Interest Expense TTM 13.1m) |
| A: 0.42 (Total Current Assets 1.01b - Total Current Liabilities 222.8m) / Total Assets 1.87b |
| B: -0.19 (Retained Earnings -359.8m / Total Assets 1.87b) |
| C: 0.04 (EBIT TTM 77.8m / Avg Total Assets 1.98b) |
| D: 0.80 (Book Value of Equity 829.6m / Total Liabilities 1.04b) |
| Altman-Z'' = 3.23 = A |
| DSRI: 1.08 (Receivables 142.3m/120.9m, Revenue 1.17b/1.07b) |
| GMI: 0.99 (GM 54.50% / 55.10%) |
| AQI: 1.19 (AQ_t 0.34 / AQ_t-1 0.29) |
| SGI: 1.09 (Revenue 1.17b / 1.07b) |
| TATA: -0.10 (NI 57.3m - CFO 241.7m) / TA 1.87b) |
| Beneish M = -2.80 (Cap -4..+1) = A |
As of July 28, 2026, the stock is trading at USD 25.55 with a total of 3,264,536 shares traded. Over the past week, the price has changed by -0.58%, over one month by +19.95%, over three months by +54.29% and over the past year by -12.35%.
Current recommended Stop Loss: 23.50 (which is 8% or 1.3 ATR below the current price).
Five9 has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy FIVN.
- StrongBuy: 12
- Buy: 6
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 27.8 | 8.8% |
P/E Trailing = 39.3538
P/E Forward = 7.8616
P/S = 1.6672
P/B = 2.3607
P/EG = 0.2278
Revenue TTM = 1.17b USD
EBIT TTM = 77.8m USD
EBITDA TTM = 185.9m USD
Long Term Debt = 736.4m USD (from longTermDebt, last quarter)
Short Term Debt = 20.9m USD (from shortTermDebt, last quarter)
Debt = 864.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 63.9m
Net Debt = 140.4m USD (calculated: Debt 864.3m - CCE 723.9m)
Enterprise Value = 2.10b USD (1.96b + Debt 864.3m - CCE 723.9m)
Interest Coverage Ratio = 5.94 (Ebit TTM 77.8m / Interest Expense TTM 13.1m)
EV/FCF = 10.70x (Enterprise Value 2.10b / FCF TTM 196.2m)
FCF Yield = 9.35% (FCF TTM 196.2m / Enterprise Value 2.10b)
FCF Margin = 16.70% (FCF TTM 196.2m / Revenue TTM 1.17b)
Net Margin = 4.87% (Net Income TTM 57.3m / Revenue TTM 1.17b)
Gross Margin = 55.10% ((Revenue TTM 1.17b - Cost of Revenue TTM 527.5m) / Revenue TTM)
Gross Margin QoQ = 55.85% (prev 54.62%)
Tobins Q-Ratio = 1.13 (Enterprise Value 2.10b / Total Assets 1.87b)
Interest Expense / Debt = 1.52% (Interest Expense 13.1m / Debt 864.3m)
Taxrate = 11.57% (7.49m / 64.7m)
NOPAT = 68.8m (EBIT 77.8m * (1 - 11.57%))
Current Ratio = 4.51 (Total Current Assets 1.01b / Total Current Liabilities 222.8m)
Debt / Equity = 1.04 (Debt 864.3m / totalStockholderEquity, last quarter 829.6m)
Debt / EBITDA = 0.76 (Net Debt 140.4m / EBITDA 185.9m)
Debt / FCF = 0.72 (Net Debt 140.4m / FCF TTM 196.2m)
Total Stockholder Equity = 777.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.89% (Net Income 57.3m / Total Assets 1.87b)
RoE = 7.37% (Net Income TTM 57.3m / Total Stockholder Equity 777.0m)
RoCE = 5.14% (EBIT 77.8m / Capital Employed (Equity 777.0m + L.T.Debt 736.4m))
RoIC = 4.29% (NOPAT 68.8m / Invested Capital 1.60b)
WACC = 8.98% (E(1.96b)/V(2.82b) * Re(12.35%) + D(864.3m)/V(2.82b) * Rd(1.52%) * (1-Tc(0.12)))
Discount Rate = 12.35% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 80.93 | Cagr: 7.77%
[DCF] Terminal Value 75.96% ; FCFF base≈156.3m ; Y1≈179.1m ; Y5≈263.6m
[DCF] Fair Price = 44.82 (EV 3.57b - Net Debt 140.4m = Equity 3.43b / Shares 76.6m; r=8.98% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 83.82 | EPS CAGR: 12.08% | SUE: 2.28 | # QB: 1
Revenue Correlation: 99.58 | Revenue CAGR: 12.87% | SUE: 1.27 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.68 | Chg30d=-8.11% | Revisions=-72% | Analysts=22
EPS next Quarter (2026-09-30): EPS=0.84 | Chg30d=+0.97% | Revisions=+48% | Analysts=22
EPS current Year (2026-12-31): EPS=3.25 | Chg30d=+0.00% | Revisions=+64% | GrowthEPS=+9.8% | GrowthRev=+9.8%
EPS next Year (2027-12-31): EPS=3.78 | Chg30d=+0.00% | Revisions=+59% | GrowthEPS=+16.1% | GrowthRev=+10.2%
[Analyst] Revisions Ratio: +25% (up=51, down=30)